Bio-Path Holdings, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 10.44 million compared to USD 10.88 million a year ago. Basic loss per share from continuing operations was USD 1.55 compared to USD 2.83 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | +0.32% | +70.97% | -65.66% |
04/06 | Bio-Path Holdings, Inc. announced that it expects to receive $4.000001 million in funding | CI |
03/06 | Sector Update: Health Care Stocks Gain Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.66% | 4.96M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- BPTH Stock
- News Bio-Path Holdings, Inc.
- Bio-Path Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021